In the TCGA dataset, we assessed the expression of key epithelial marker E-cadherin (CDH1) and mesenchymal markers, including vimentin (VIM), MMP9, SNAI2, ZEB1, and ZEB2, about VISTA expression in breast cancer patients using Spearman correlation analysis (Figure 5). Here, ZEB2 is linked to breast cancer.